Morgan Stanley disclosure shows 6.9% stake in Roivant (ROIV)

Rhea-AI Filing Summary

Roivant Sciences Ltd. ownership update: Morgan Stanley and Morgan Stanley Investment Management Inc. file an amended Schedule 13G/A reporting beneficial ownership stakes in Roivant common shares. The filing shows 6.9% of the class (Morgan Stanley) and 6.7% (MSIM) with shared voting and dispositive powers disclosed.

The filing attributes specific shared voting power and shared dispositive power amounts to the reporting entities and states the submission is made on behalf of certain operating units collectively described as the "MS Reporting Units." Signature blocks and exhibits (Joint Filing Agreement; Item 7 information) are included.

Insights

Institutional Ownership Analyst

Amendment clarifies institutional beneficial ownership and voting/dispositive power.

The schedule lists shared voting power of 44,317,733 shares and shared dispositive power of 49,390,771 shares for Morgan Stanley, and similar figures for Morgan Stanley Investment Management Inc. These are presented as beneficial ownership percentages of the class: 6.9% and 6.7%, respectively.

This filing states the holdings are aggregated for certain "MS Reporting Units." Subsequent disclosures or exhibits may identify the subsidiary reporting units; timing and cash‑flow treatment are not specified in the excerpt.

Key Figures

Morgan Stanley percent of class: 6.9% MSIM percent of class: 6.7% Morgan Stanley shared voting power: 44,317,733 shares +3 more

6 metrics

Morgan Stanley percent of class 6.9% Item 4(b) beneficial ownership percentage

MSIM percent of class 6.7% Item 4(b) beneficial ownership percentage for Morgan Stanley Investment Management Inc.

Morgan Stanley shared voting power 44,317,733 shares cover-page response to Item 6 (shared voting power)

Morgan Stanley shared dispositive power 49,390,771 shares cover-page response to Item 8 (shared dispositive power)

MSIM shared dispositive power 48,260,685 shares cover-page response to Item 8 for Morgan Stanley Investment Management Inc.

CUSIP G76279101 Issuer common shares CUSIP on cover

Key Terms

Schedule 13G/A, MS Reporting Units, shared dispositive power, Joint Filing Agreement

4 terms

Schedule 13G/A regulatory

"Amended Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

MS Reporting Units financial

"securities beneficially owned by certain operating units (collectively, the "MS Reporting Units")"

shared dispositive power regulatory

"Shared Dispositive Power 49,390,771.00 appears on cover responses"

Joint Filing Agreement legal

"Exhibit 99.1 Joint Filing Agreement listed in exhibits"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Roivant Sciences Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

G76279101

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G76279101

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 44,317,733.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 49,390,771.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

49,473,835.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP Number(s): G76279101

1

Names of Reporting Persons

Morgan Stanley Investment Management Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 43,178,724.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 48,260,685.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

48,260,685.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.7 %

12

Type of Reporting Person (See Instructions)

IA, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Roivant Sciences Ltd.
(b)	Address of issuer's principal executive offices: 7TH FLOOR, 50 BROADWAY, LONDON, X0, SW1H 0DB
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Investment Management Inc.
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: G76279101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	05/12/2026

Morgan Stanley Investment Management Inc.

Signature:	Deidre A. Downes
Name/Title:	Authorized Signatory, Morgan Stanley Investment Management Inc.
Date:	05/12/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).

FAQ

What stake does Morgan Stanley report in Roivant (ROIV)?

Morgan Stanley reports beneficial ownership of 6.9% of Roivant common shares. The amended Schedule 13G/A lists shared voting power of 44,317,733 and shared dispositive power of 49,390,771.

The filing covers holdings reported by certain operating units collectively called the "MS Reporting Units," and includes exhibits and signatures from authorized signatories.

What does Morgan Stanley Investment Management disclose for ROIV?

Morgan Stanley Investment Management Inc. reports beneficial ownership of 6.7% of the class. The filing shows shared voting power of 43,178,724 and shared dispositive power of 48,260,685.

These figures appear on the cover responses referenced under Item 9 and are filed as an amendment to Schedule 13G/A.

Does this Schedule 13G/A indicate sole voting or dispositive power for MS?

The filing shows zero sole voting and sole dispositive power for the reporting entities and reports only shared powers. The cover rows list sole voting power and sole dispositive power as 0.00.

Shared voting and dispositive powers are provided as the relevant control metrics in the submission.

Who signed the amended Schedule 13G/A for Roivant (ROIV)?

The amendment is signed by authorized signatories: Claire Gordon for Morgan Stanley and Deidre A. Downes for Morgan Stanley Investment Management Inc. with signature dates shown as 05/12/2026.

Exhibits referenced include a Joint Filing Agreement and Item 7 information about any subsidiary reporting units.

What is the filing’s scope regarding Morgan Stanley holdings?

The filing covers securities beneficially owned or deemed beneficially owned by certain operating units collectively called the "MS Reporting Units." It excludes any units disaggregated per Release No. 34-39538 rules.

Further identification of subsidiary reporters is referenced in Exhibit 99.2; the excerpt does not list subsidiary names directly.